Cumberland Pharmaceuticals CPIX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestExpense.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's interest expense?
- Cumberland Pharmaceuticals (CPIX) reported interest expense of $85.84K in Q1 2026.
- How has Cumberland Pharmaceuticals's interest expense changed year-over-year?
- Cumberland Pharmaceuticals's interest expense decreased by 47.6% year-over-year, from $163.8K to $85.84K.
- What is the long-term trend for Cumberland Pharmaceuticals's interest expense?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's interest expense has grown at a 50.0% compound annual growth rate (CAGR), from $98.03K to $495.99K.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.